MedTrace Logo

Eradication of Prostate Cancer Using F-989

NCT01987999 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-09-20

No results posted yet for this study

Summary

The purpose of this study is to confirm the findings of an early study with prostate cancer and to expand our knowledge of treating prostate cancer using F-989.

Conditions

Interventions

DIETARY_SUPPLEMENT

Acetogenins

Sponsors & Collaborators

  • Optimal Health Research

    lead OTHER

Principal Investigators

  • Steven Osguthorpe, ND · Optimal Health Research

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01987999 on ClinicalTrials.gov